Cannabidiol Mitigates Lipopolysaccharide-Induced Pancreatic Pathology: A Promising Therapeutic Strategy
Cannabis and Cannabinoid Research · 2024
DOI: 10.1089/can.2023.0153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cannabis and Cannabinoid Research, 2024. Verfasst von Senay Topsakal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University, Denizli, Turkey. Hauptthemen laut MEDLINE: Cannabidiol, Lipopolysaccharides, Pancreas. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University, Denizli, Turkey.
- Department of Pathology, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
- Department of Pharmacology, Faculty of Pharmacy, Suleyman Demirel University, Isparta, Turkey.
- Department of Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
- Genetic Research Unit, Innovative Technologies Application and Research Center, Suleyman Demirel University, Isparta, Turkey.
ORCID-Profile: Senay Topsakal, Ozlem Ozmen, Nasif Fatih Karakuyu, Mehmet Bedir, Okan Sancer
Zitieren
APA
Topsakal, S., Ozmen, O., Karakuyu, N. F., Bedir, M., & Sancer, O. (2024). Cannabidiol Mitigates Lipopolysaccharide-Induced Pancreatic Pathology: A Promising Therapeutic Strategy. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2023.0153
Vancouver
Topsakal S, Ozmen O, Karakuyu NF, Bedir M, Sancer O. Cannabidiol Mitigates Lipopolysaccharide-Induced Pancreatic Pathology: A Promising Therapeutic Strategy. Cannabis and Cannabinoid Research. 2024. doi:10.1089/can.2023.0153
BibTeX
@article{Topsakal2024,
author = {Topsakal, Senay and Ozmen, Ozlem and Karakuyu, Nasif Fatih and Bedir, Mehmet and Sancer, Okan},
title = {Cannabidiol Mitigates Lipopolysaccharide-Induced Pancreatic Pathology: A Promising Therapeutic Strategy},
journal = {Cannabis and Cannabinoid Research},
year = {2024},
doi = {10.1089/can.2023.0153}
}
EUVIMED